آسيا · أخبار عامة · The Japan Times

Health ministry questions reliability of vasculitis drug approval data

نشره The Japan Times · اليابان منذ 1 س

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

اقرأ المقال كاملًا على The Japan Times سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.japantimes.co.jp)

يستحق القراءة أيضًا

Philippine Daily Inquirer

Wrong anthems played at Asian Para Games

Chinese-linked hackers compromise ConnectWise, target hundreds in global attack

VnExpress International

Saigon River's palm-leaf-shaped pedestrian bridge completes final span ahead of 2027 opening

North Korea's Kim Yo Jong warns South Korea, says border loudspeakers to be ready within days

Hindustan Times

In 2018, DNA from wild canines on a Texas island revealed genes from red wolves, a species declared extinct in the wild nearly four decades earlier

Takaichi’s next vote is in the bond market